{
 "PrintNo":"S2926","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-25T13:14:51.21471Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-01-25","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1504,"Name":"Cordell Cleare","Short":"CLEARE"}],
 "Title":"Authorizes reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs",
 "Summary":"Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs",
 "SameAsPrintNo":"A1792-2023",
 "PreviousVersions":["A4447-2007","A1134-2009","A264-2011","A4372-2013","A299-2015","A2667-2017","A2846-2019","S8572-2021"]
}